Login
$AKTX
$7.63 -$0.59 (7.23%) Close

$AKTX SEC Filings

Filed On Filing
16 Oct 2026 Form 4: Prudo-Chlebosz Raymond, Director

Received 9,072 shares as a grant or award ($71.7K) · Granted 45,000 Stock Option (Right to Buy) · Received 3,240 shares as a grant or award ($25.6K)

16 Oct 2026 Form 4: Huh Hoyoung, Director

Received 17,249 shares as a grant or award ($136K) · Granted 45,000 Stock Option (Right to Buy) · Received 6,160 shares as a grant or award ($48.7K)

16 Oct 2026 Form 4: Patel Sandip I, Director

Received 12,100 shares as a grant or award ($95.6K) · Granted 60,000 Stock Option (Right to Buy) · Received 4,313 shares as a grant or award ($34.1K) · 1 more

16 Oct 2026 Form 4: Bazemore Robert B, Director

Received 13,100 shares as a grant or award ($103K) · Granted 60,000 Stock Option (Right to Buy) · Received 4,677 shares as a grant or award ($36.9K) · 1 more

16 Oct 2026 Form 4: Gaslightwala Abizer, Director

Granted 174,000 Stock Option (Right to Buy) · Received 27,066 shares by exercise or conversion ($10.8)

16 Oct 2026 Form 4: Patel Samir Rashmikant, Director

Received 6,300 shares as a grant or award ($49.8K) · Granted 45,000 Stock Option (Right to Buy) · Received 2,236 shares as a grant or award ($17.7K)

14 Oct 2026 Form 4: Vat-Ho Vatnak, Chief Business Officer

Granted 87,000 Stock Option (Right to Buy)

14 Oct 2026 Form 3: Vat-Ho Vatnak, Chief Business Officer

No securities owned

01 Oct 2026 Form 4: Gaslightwala Abizer, Director

Received 6,430 shares as a grant or award ($62.5K)

01 Oct 2026 Proxy statement: annual meeting on October 28, 2026
01 Oct 2026 8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

This AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is entered into as of September 29, 2026, by and between Akari Therapeutics, Plc (the “Company”) and you, Abizer Gaslightwala (individually, a “Party,” and collectively, the “Part...

19 Aug 2026 Form 4: Farag Kameel D., Interim CFO

Received 1,728 shares as a grant or award ($13K)

13 Aug 2026 10-Q
13 Aug 2026 8-K: Results of Operations and Financial Condition
12 Aug 2026 SCHEDULE 13G
07 Aug 2026 SCHEDULE 13G
05 Aug 2026 Form 4: Farag Kameel D., Interim CFO

Received 1,130 shares as a grant or award ($13K)

17 Jul 2026 Form 4: Patel Samir Rashmikant, Director

Received 22,474 shares by exercise or conversion ($9.68K) · Acquired 1,209 Pre-Funded Warrant to purchase American Depositary Shares (Option Exercise/Conversion) ($38.7K) · Acquired 21,265 Pre-Funded Warrant to purchase ADSs (Option Exercise/Conversion) ($344K)

13 Jul 2026 EFFECT
10 Jul 2026 S-3/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support